Increasing drowsiness and respiratory depression in an older patient with renal impairment
A pharmacovigilance case for causality assessment: work out which drug is responsible, grade the reaction's severity and seriousness, and defend a causality category using the WHO-UMC causality assessment.
WHO-UMC causality assessment
- Framework
- WHO-UMC causality assessment
- You decide
- Suspect drug, reaction, severity, seriousness, causality
The case
Mr A, a 78-year-old man, was admitted electively for a hip fracture repair. His medical history included hypertension and mild chronic kidney disease (baseline creatinine 90 μmol/L). On the day of admission, he was started on oral morphine sulfate solution 10 mg every four hours when required for pain. His usual antihypertensive, amlodipine 5 mg once daily, was continued. On day 2, because of significant postoperative anxiety, oral lorazepam 1 mg at night was added. On day 5, the nursing staff noted he was increasingly drowsy and difficult to rouse. His respiratory rate was recorded at 8 breaths per minute, with an oxygen saturation of 89% on room air. Arterial blood gas analysis showed a respiratory acidosis: pH 7.25, PaCO2 8.6 kPa. His serum creatinine on day 6 had risen to 180 μmol/L, a doubling from baseline. Examination revealed pinpoint pupils, no focal neurological deficit, and no evidence of infection. The morphine was withheld, and lorazepam was also withheld. Within 12 hours, his respiratory rate returned to 14 breaths per minute and he became more alert. Over the next 24 hours, his renal function remained impaired but stable. No rechallenge with morphine was performed. Alternative explanations, such as acute kidney injury from dehydration or the effects of his other medications, were considered.
What you are asked to do
- Identify which of the patient's drugs is the suspect, and say why the others are not.
- Name the reaction and grade its severity.
- Decide whether it is serious by regulatory criteria, which is not the same as severe.
- Assign a causality category under the WHO-UMC causality assessment and justify it from the timeline, the dechallenge and the alternative causes.
- State the management and what should be reported.
The suspect drug and the graded answer are deliberately not on this page: working them out is the exercise.
Log in to assess "Increasing drowsiness and respiratory depression in an older patient with renal impairment"
A free account opens the trainer: name the suspect drug, grade the reaction and commit to a causality category, then see how your assessment compares and why.
More like this
- Jaundice and elevated ALT in a woman on tuberculosis treatment
- Lip and tongue swelling in a 60-year-old man
- Lithium toxicity after introduction of bendroflumethiazide
- Maculopapular Rash in a 19-Year-Old on Antibiotics for Sore Throat
- Melaena and INR 8.5 in a 76-year-old woman on warfarin after starting clarithromycin
- Nausea, yellow-tinged vision and bradycardia in an 80-year-old woman on digoxin
Educational content for students and clinicians in training. It does not replace professional judgement, local protocols or current prescribing information.